GSK and Vir Biotechnology entered collaboration to find coronavirus solutions
On Apr. 6, 2020, GSK and Vir Biotechnology announced a binding agreement to enter into a collaboration to…
On Apr. 6, 2020, GSK and Vir Biotechnology announced a binding agreement to enter into a collaboration to…
On Apr. 6, 2020, Intravacc announced development of an intranasal vaccine against COVID-19 that will be developed through…
On Apr. 6, 2020, Mateon Therapeutics announced an update on its rapid antiviral response program targeting coronaviruses, initially…
On Apr. 6, 2020, OncoSec Medical announced that Providence Cancer Institute, a part of Providence St. Joseph Health…
On Apr. 6, 2020, Innovation Pharma announced that it is engaged in discussions with health care provider networks…
On Apr. 6, 2020, OraSure Technologies announced it has been awarded a $710,310 contract from the Biomedical Advanced…
On Apr. 6, 2020, the USDA confirmed SARS-CoV-2 (the virus that causes COVID-19 in humans) in one tiger…
On Apr. 6, 2020, Luminex announced announced that the FDA has issued an Emergency Use Authorization for its…
On Apr. 6, 2020, VGXI, announced it has completed manufacturing and release of a DNA vaccine to combat…
On Apr. 6, 2020, Rice University announced it had established a research accelerator fund to support projects –…
On Apr. 4, 2020, Mesa Biotech announced the addition of the novel coronavirus (SARS-CoV-2) to its active influenza…
On Apr. 3, 2020, the University of Minnesota announced it had created the stateï¾’s fourth on-site testing facility…
On Apr. 3, 2020, BD (Becton, Dickinson) and BioGX announced that the U.S. Food and Drug Administration (FDA)…
On Apr. 3, 2020, OHSU announced that it had established an in-house COVID-19 testing lab that OHSU staff…
On Apr. 3, 2020, XBiotech and BioBridge Global announced a collaboration to participate in a FDA investigational program…
On Apr. 2, 2020, an international team led by University of British Columbia researcher Dr. Josef Penninger announced…
On Apr. 2, 2020, Cerus announced that the University Hospital Basel transfused the first two COVID-19 patients with…
On Apr. 2, 2020, Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic….
On Apr. 2, 2020, Vanda Pharmaceuticals announced initiation of clinical study, ODYSSEY VLY-686-3501, in hospitalized patients with COVID-19….
On Apr. 2, 2020, Emergent BioSolutions announced it has entered into a formal partnership with the U.S. government…
On Apr. 2, 2020, CHF Solutions announced it has doubled the production staff that builds its next generation…
On Apr. 2, 2020, Roswell Park Comprehensive Cancer Center and the University at Buffalo (UB) launched a collaborative…
On Apr. 2, 2020, Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic….
On Apr. 2, 2020, an international collaboration of virologists at the University of Wisconsinï¾–Madison and the vaccine companies…
On Apr. 1, 2020, ImmunityBio, a privately held immunotherapy company within the NantWorks ecosystem of companies, announced it…
On Apr. 1, 2020, Innovation Pharma it had received data supporting Brilacidinï¾’s direct inhibition of SARS-CoV-2, the novel…
On Apr. 1, 2020, a study of 24 of the most critically ill patients with COVID-19, early on…
On Mar. 31, 2020, FUJIFILM announced initiation of a phase III clinical trial to evaluate the safety and…
On Mar. 31, 2020, Vaxart announced it had produced five COVID-19 vaccine candidates for testing in its preclinical…
On Mar. 31, 2020, Chembio Diagnostics announced the U.S. launch of the rapid DPP COVID-19 serological point-of-care test…